Species-Specific Quantitative Proteomics Profiles of Sarcoma Patient-Derived Models Closely Reflect Their Primary Tumors.


Journal

Proteomics. Clinical applications
ISSN: 1862-8354
Titre abrégé: Proteomics Clin Appl
Pays: Germany
ID NLM: 101298608

Informations de publication

Date de publication:
11 2019
Historique:
received: 26 03 2019
revised: 25 07 2019
pubmed: 17 8 2019
medline: 15 5 2020
entrez: 17 8 2019
Statut: ppublish

Résumé

The purpose is to examine whether patient-derived sarcoma models recapitulate the spectrum of sarcoma heterogeneity seen in patients. To characterize patient-derived models for functional studies, proteomic comparisons with originating sarcomas representative of three intrinsic subtypes by MS are performed. Human protein profiling is found to be retained with high fidelity in patient-derived models. The protein profiles of patient sarcoma tumors and mouse stroma are characterized by species-specific quantitative proteomics. Protein-expression levels in mouse stroma are affected by the primary human tumor. The levels of stromal proteins derived from tumors are lower in PDXs and cell lines, and some human stromal proteins are replaced by the corresponding mouse proteins in PDXs. These findings suggest that the effects of the microenvironment on drug responses may not reflect those in the primary tumor. This cross-species proteomic analysis in PDXs can potentially improve preclinical evaluation of treatment modalities and enhance the ability to predict clinical trial responses.

Identifiants

pubmed: 31419061
doi: 10.1002/prca.201900054
doi:

Substances chimiques

Proteome 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1900054

Informations de copyright

© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Références

M. Ladanyi, J. Alexander, S. Singer, Cell 2017, 171, 950.
K. G. Billingsley, M. E. Burt, E. Jara, R. J. Ginsberg, J. M. Woodruff, D. H. Leung, M. F. Brennan, Ann. Surg. 1999, 229, 602.
J. J. Salk, E. J. Fox, L. A. Loeb, NIH Public Access 2012, 51.
Y. Takai, R. Oyama, F. Kito, M. Sakumoto, K. Shiozawa, Tiss. Cult. Res. Comm. 2017, 48, 41.
R. Oyama, M. Takahashi, A. Yoshida, M. Sakumoto, Y. Takai, F. Kito, K. Shiozawa, Z. Qiao, Y. Arai, T. Shibata, Y. Araki, M. Endo, A. Kawai, T. Kondo, Sci. Rep. 2017, 7, 4712.
M. Sakumoto, M. Takahashi, R. Oyama, Y. Takai, F. Kito, K. Shiozawa, Z. Qiao, A. Yoshida, M. Endo, A. Kawai, T. Kondo, Jpn. J. Clin. Oncol. 2017, 47, 954.
M. Sakumoto, R. Oyama, M. Takahashi, Y. Takai, F. Kito, K. Shiozawa, Z. Qiao, M. Endo, A. Yoshida, A. Kawai, T. Kondo, In Vitro Cell. Dev. Biol. Anim. 2018, 54, 163.
F. Kito, R. Oyama, M. Takahashi, K. Shiozawa, M. Sakumoto, A. Yoshida, N. Setsu, E. Kobayashi, A. Kawai, T. Kondo, Tiss. Cult. Res. Commun. 2018, 37, 133.
R. Oyama, M. Takahashi, F. Kito, M. Sakumoto, Y. Takai, S. Kumiko, Z. Qiao, S. Toki, Y. Tanzawa, A. Yoshida, A. Kawai, T. Kondo, Tiss. Cult. Res. Commun. 2019, 38, 1.
R. Oyama, F. Kito, M. Sakumoto, K. Shiozawa, S. Toki, A. Yoshida, A. Kawai, T. Kondo, In Vitro Cell. Dev. Biol. Anim. 2018, 54, 257.
F. Kito, R. Oyama, Y. Takai, M. Sakumoto, K. Shiozawa, Z. Qiao, T. Uehara, A. Yoshida, A. Kawai, T. Kondo, Hum. Cell 2018, 31, 167.
R. Oyama, M. Takahashi, F. Kito, M. Sakumoto, K. Shiozawa, Z. Qiao, A. Yoshida, M. Endo, A. Kawai, T. Kondo, In Vitro Cell. Dev. Biol. Anim. 2018, 54, 458.
F. Kito, R. Oyama, M. Sakumoto, M. Takahashi, K. Shiozawa, Z. Qiao, H. Sakamoto, T. Hirose, N. Setsu, A. Yoshida, A. Kawai, T. Kondo, In Vitro Cell. Dev. Biol. Anim. 2018, 54, 528.
R. Oyama, F. Kito, Z. Qiao, M. Sakumoto, R. Noguchi, M. Takahashi, S. Toki, Y. Tanzawa, A. Yoshida, A. Kawai, T. Kondo, In Vitro Cell. Dev. Biol. Anim. 2018, 54, 770.
S. P. Chiang, R. M. Cabrera, J. E. Segall, Am. J. Physiol.: Cell Physiol. 2016, 311, C1.
M. J. Pittet, R. Weissleder, Cell 2011, 147, 983.
R. S. Watnick, Cold Spring Harb. Perspect. Med. 2012, 2, a006676.
T. Masuda, M. Tomita, Y. Ishihama, J. Proteome Res. 2008, 7, 731.
M. Ono, M. Shitashige, K. Honda, T. Isobe, H. Kuwabara, H. Matsuzuki, S. Hirohashi, T. Yamada, Mol. Cell. Proteomics 2006, 5, 1338.
M. Ono, M. Kamita, Y. Murakoshi, J. Matsubara, K. Honda, B. Miho, T. Sakuma, T. Yamada, Int. J. Proteomics 2012, 2012, 1.
D. W. Huang, B. T. Sherman, R. A. Lempicki, Nucleic. Acids. Res. 2009, 37, 1.
D. W. Huang, B. T. Sherman, R. A. Lempicki, Nat. Protoc. 2009, 4, 44.
A. Sica, A. Mantovani, J. Clin. Invest. 2012, 122, 787.
Y. Luo, H. Zhou, J. Krueger, C. Kaplan, S. H. Lee, C. Dolman, D. Markowitz, W. Wu, C. Liu, R. A. Reisfeld, R. Xiang, J. Clin. Invest. 2006, 116, 2132.
F. Zhang, H. Liu, G. Jiang, H. Wang, X. Wang, H. Wang, R. Fang, S. Cai, J. Du, Proteomics 2015, 15, 773.
J. Condeelis, J. W. Pollard, Cell 2006, 124, 263.
R. Noy, J. W. Pollard, Immunity 2014, 41, 49.
S. Torres, R. A. Bartolome, M. Mendes, R. Barderas, M. J. Fernandez-Acenero, A. Pelaez-Garcia, C. Pena, M. Lopez-Lucendo, R. Villar-Vazquez, A. G. de Herreros, F. Bonilla, J. I. Casal, Clin. Cancer Res. 2013, 19, 6006.
S. Pavlides, D. Whitaker-Menezes, R. Castello-Cros, N. Flomenberg, A. K. Witkiewicz, P. G. Frank, M. C. Casimiro, C. Wang, P. Fortina, S. Addya, R. G. Pestell, U. E. Martinez-Outschoorn, F. Sotgia, M. P. Lisanti, Cell Cycle 2009, 8, 3984.
U. E. Martinez-Outschoorn, M. P. Lisanti, F. Sotgia, Semin. Cancer Biol. 2014, 25, 47.
A. Casazza, G. Di Conza, M. Wenes, V. Finisguerra, S. Deschoemaeker, M. Mazzone, Oncogene 2014, 33, 1743.
M. Y. Fong, W. Zhou, L. Liu, A. Y. Alontaga, M. Chandra, J. Ashby, A. Chow, S. T. O'Connor, S. Li, A. R. Chin, G. Somlo, M. Palomares, Z. Li, J. R. Tremblay, A. Tsuyada, G. Sun, M. A. Reid, X. Wu, P. Swiderski, X. Ren, Y. Shi, M. Kong, W. Zhong, Y. Chen, S. E. Wang, Nat. Cell Biol. 2015, 17, 183.
X. Wang, A. D. Mooradian, P. Erdmann-Gilmore, Q. Zhang, R. Viner, S. R. Davies, K. L. Huang, R. Bomgarden, B. A. van Tine, J. Shao, L. Ding, S. Li, M. J. Ellis, J. C. Rogers, R. R. Townsend, D. Fenyö, J. M. Held, Sci. Signal. 2017, 10, eaam8065.
H. Hahn, L. Wojnowski, A. M. Zimmer, J. Hall, G. Miller, A. Zimmer, Nat. Med. 1998, 4, 619.
W. M. Roberts, E. C. Douglass, S. C. Peiper, P. J. Houghton, A. T. Look, Cancer Res. 1989, 12, 5407.
S. Zhan, L. J. Helman, Nat. Med. 1998, 4, 559.
U. Ben-David, G. Ha, Y. Y. Tseng, N. F. Greenwald, C. Oh, J. Shih, J. M. McFarland, B. Wong, J. S. Boehm, R. Beroukhim, T. R. Golub, Nat. Genet. 2017, 49, 1567.

Auteurs

Kumiko Shiozawa (K)

Division of Rare Cancer Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

Rieko Oyama (R)

Department of Innovative Seeds Evaluation, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

Mami Takahashi (M)

Central Animal Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

Fusako Kito (F)

Department of Innovative Seeds Evaluation, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

Emi Hattori (E)

Division of Rare Cancer Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

Akihiko Yoshida (A)

Pathology and Clinical Laboratory Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

Akira Kawai (A)

Division of Musculoskeletal Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

Masaya Ono (M)

Department of Clinical Proteomics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

Tadashi Kondo (T)

Division of Rare Cancer Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Department of Innovative Seeds Evaluation, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH